These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23519920)

  • 1. Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.
    Passarelli MN; Newcomb PA; LaCroix AZ; Lane DS; Ho GY; Chlebowski RT
    J Bone Miner Res; 2013 Sep; 28(9):2043-8. PubMed ID: 23519920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral bisphosphonate use and lung cancer incidence among postmenopausal women.
    Tao MH; Chen S; Freudenheim JL; Cauley JA; Johnson KC; Mai X; Sarto GE; Wakelee H; Boffetta P; Wactawski-Wende J
    Ann Oncol; 2018 Jun; 29(6):1476-1485. PubMed ID: 29617712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bisphosphonate use and risk of postmenopausal endometrial cancer.
    Newcomb PA; Passarelli MN; Phipps AI; Anderson GL; Wactawski-Wende J; Ho GY; O'Sullivan MJ; Chlebowski RT
    J Clin Oncol; 2015 Apr; 33(10):1186-90. PubMed ID: 25713431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bisphosphonate use and breast cancer incidence in postmenopausal women.
    Chlebowski RT; Chen Z; Cauley JA; Anderson G; Rodabough RJ; McTiernan A; Lane DS; Manson JE; Snetselaar L; Yasmeen S; O'Sullivan MJ; Safford M; Hendrix SL; Wallace RB
    J Clin Oncol; 2010 Aug; 28(22):3582-90. PubMed ID: 20567009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.
    Drieling RL; LaCroix AZ; Beresford SA; Boudreau DM; Kooperberg C; Chlebowski RT; Gass M; Crandall CJ; Womack CR; Heckbert SR
    Menopause; 2016 Nov; 23(11):1168-1175. PubMed ID: 27433859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chocolate Candy and Incident Invasive Cancer Risk in the Women's Health Initiative: An Observational Prospective Analysis.
    Greenberg JA; Neuhouser ML; Tinker LF; Lane DS; Paskett ED; Van Horn LV; Wassertheil-Smoller S; Shikany JM; Qi L; Sealy-Jefferson S; Manson JE
    J Acad Nutr Diet; 2021 Feb; 121(2):314-326.e4. PubMed ID: 32763064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.
    Drieling RL; LaCroix AZ; Beresford SAA; Boudreau DM; Kooperberg C; Chlebowski RT; Ko MG; Heckbert SR
    J Am Geriatr Soc; 2017 Sep; 65(9):1924-1931. PubMed ID: 28555811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
    Pazianas M; Abrahamsen B; Eiken PA; Eastell R; Russell RG
    Osteoporos Int; 2012 Nov; 23(11):2693-701. PubMed ID: 22392160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of bisphosphonate use and risk of colorectal cancer.
    Khalili H; Huang ES; Ogino S; Fuchs CS; Chan AT
    J Clin Oncol; 2012 Sep; 30(26):3229-33. PubMed ID: 22649131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to oral bisphosphonates and risk of cancer.
    Cardwell CR; Abnet CC; Veal P; Hughes CM; Cantwell MM; Murray LJ
    Int J Cancer; 2012 Sep; 131(5):E717-25. PubMed ID: 22161552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive and menstrual factors and colorectal cancer incidence in the Women's Health Initiative Observational Study.
    Murphy N; Xu L; Zervoudakis A; Xue X; Kabat G; Rohan TE; Wassertheil-Smoller S; O'Sullivan MJ; Thomson C; Messina C; Strickler HD; Gunter MJ
    Br J Cancer; 2017 Jan; 116(1):117-125. PubMed ID: 27898658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in colorectal cancer incidence and mortality in the Women's Health Initiative.
    Simon MS; Thomson CA; Pettijohn E; Kato I; Rodabough RJ; Lane D; Hubbell FA; O'Sullivan MJ; Adams-Campbell L; Mouton CP; Abrams J; Chlebowski RT
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1368-78. PubMed ID: 21602308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to oral bisphosphonates and risk of esophageal cancer.
    Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
    JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature.
    Liu Y; Zhao S; Chen W; Hu F; Zhu L; Zhang Q; Zhao Y
    Clin Breast Cancer; 2012 Aug; 12(4):276-81. PubMed ID: 22622199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
    Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
    BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid.
    Hue TF; Cummings SR; Cauley JA; Bauer DC; Ensrud KE; Barrett-Connor E; Black DM
    JAMA Intern Med; 2014 Oct; 174(10):1550-7. PubMed ID: 25111880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between NSAID use and colorectal cancer mortality: results from the women's health initiative.
    Coghill AE; Phipps AI; Bavry AA; Wactawski-Wende J; Lane DS; LaCroix A; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1966-73. PubMed ID: 22933426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.